Author
The author works as a Correspondent with BW Businessworld
Indian medical technology industry is moving in the right direction with exciting times ahead although the sector needs improvements in many aspects and still has a long way to go to reduce the 80 to 85 per cent import dependency of the Indian healthcare system when it comes to using medical devices in hospitals and diagnostic labs
Read More
Chennai-based drug firm, Global Pharma Healthcare, voluntarily recalled its whole batch of eye drops after the USFDA notification alleged that they had caused a death and 55 instances of eye infections and permanent loss of vision
Read More
Biocon's revenue for the third quarter stood at Rs 3,020 crores against Rs 2,223 crores in the same quarter last year. Whereas the company posted a net loss of Rs 42 crores in quarter three of the financial year 2023(Q3FY23
Read More
In an exclusive interaction with BW Healthcare World, RK Baheti, CFO, Alembic Pharmaceuticals speaks on the headwinds for generics, the progress of PLI schemes in pharma, updates on the USFDA inspections, takeaways from the budget and the company's outlook in the upcoming financial year
Read More
Dr Shuchin Bajaj, Founder Director, Ujala Cygnus Hospitals speaks with BW Healthcare World on the evolving scenario of tier 2 and tier 3 cities, maintaining profitability, operating on low costs, leveraging technology and overcoming challenges of delivering healthcare in the towns
Read More
Alembic Pharma recorded a Profit After Tax (PAT) of Rs 122 crores in quarter three of the financial year 2023 (Q3FY23) against Rs 171 crores recorded in the corresponding quarter of the previous year, a 29 per cent slump year on year
Read More
The overall budget outlay given to the Ministry of Health and Family Welfare has increased by 3.42 per cent against Rs 86,200 crores given in the FY2021-22. While the health research corpus dipped by 6.8 per cent from Rs 3,200 crores in the FY22-23, a contraction of Rs 220 crores
Read More
Glenmark Pharmaceuticals recorded a net profit of Rs 105 crores in quarter three of the financial year 2023(Q3FY23) against Rs 103.7 crores recorded in the corresponding quarter in the previous year, a 1.2 per cent jump year on year while the PAT dropped by 1.2 per cent quarter on quarter
Read More
In an interaction with BW Healthcare World, Dr Vikas Gupta, India Business Rx Head, Cipla speaks on the causes of the increasing asthma burden of India, its solutions, stigmas, challenges and awareness and management of the disease
Read More
In an exclusive conversation with Shivam Tyagi, BW Healthcare World, Krishnan Ramachandran, MD and CEO of Niva Bupa Health Insurance speaks on the growth of health insurance sector in the year 2022, outlook for 2023, finding the missing middle, trust deficit between hospitals and insurers and bringing on more services under the standard health insurance policies
Read More
